Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. Januar 2024 08:30 ET | Quelle: CorMedix, Inc.

CorMedix Inc. Announces Commercial and Operational Updates

BERKELEY HEIGHTS, N.J., Jan. 08, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
08. Januar 2024 08:30 ET | Quelle: Globex Mining Enterprises Inc.

Globex Receives Payments to Finalize Uranium Property Acquisition by Infini Resources

ROUYN-NORANDA, Quebec, Jan. 08, 2024 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS...
08. Januar 2024 08:30 ET | Quelle: Oatly AB

Oatly Launches Two New Oatmilk Varieties, Marking the Company’s First Major Innovations to its Core North American Beverage Portfolio in Five Years

MALMÖ, Sweden, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Oatly Group AB (Nasdaq: OTLY)(“Oatly” or the “Company”), the world’s original and largest oat drink company, today announced the nationwide...
08. Januar 2024 08:01 ET | Quelle: Vera Therapeutics

Vera Therapeutics Announces Appointment of Industry Veterans Robert Brenner, M.D. as Chief Medical Officer and William D. Turner as Chief Development Officer

BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and commercializing transformative treatments for...
08. Januar 2024 08:00 ET | Quelle: HP Inc.

CES 2024: HP Transforms Consumer Portfolio to Power the Personal

News Highlights: Experience your newest personalized companion with HP Spectre x360 laptops, the world’s most adaptive PCs with built-in AI technology,1 the world’s most advanced convertible...
08. Januar 2024 08:00 ET | Quelle: Vera Therapeutics

Vera Therapeutics to Host In-Person R&D Day in New York to Present Week 72 Data from Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN on January 25, 2024

BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and commercializing transformative treatments for...
08. Januar 2024 08:00 ET | Quelle: NewAmsterdam Pharma N.V

NewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors

NAARDEN, The Netherlands and MIAMI, Jan. 08, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a clinical-stage biopharmaceutical company...
08. Januar 2024 08:00 ET | Quelle: Aclarion, Inc.

Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan

Partnership aims to include Aclarion’s surgical decision support technology within ATEC’s AlphaInformatiX platform to better inform spine surgery Aclarion’s Nociscan is the first augmented...
08. Januar 2024 08:00 ET | Quelle: Landos Biopharma, Inc.

Landos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisation

NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP) (“Landos” or the “Company”), a clinical-stage biopharmaceutical company developing novel, oral medicines for...
08. Januar 2024 07:48 ET | Quelle: NowVertical Group Inc

NowVertical Announces Board and Management Changes Enhancing Capital Markets, Financial Governance and Operational Expertise

TORONTO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (“NowVertical” or the “Company”) (TSX-V: NOW) (OTCQB: NOWVF), a leading force in data analytics and AI solutions, is pleased to...

Vorherige Seite

Nächste Seite